Home › Non-Hodgkin Lymphoma › Texas › Dallas

Pag-aaral pangklinika para sa Non-Hodgkin Lymphoma sa Dallas, TX

Isang pag-aaral para sa Non-Hodgkin Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Nagre-recruitPhase 2

UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04728893

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Nagre-recruitPhase 1/2

Baylor Scott & White Research Institute, Texas Oncology, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06343311

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

University of Texas Southwestern, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1

Texas Oncology - DFW (Sammons CC), Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 1

Baylor University Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03666000

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Baylor University Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Nagre-recruitObservasyonal na pag-aaral

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06116110

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Medical City Dallas, Dallas
Children's Medical Center Dallas, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL

Nagre-recruitPhase 1/2

University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2026 · NCT06768905

Study of SGR-1505 in Mature B-Cell Neoplasms

Nagre-recruitPhase 1

University of Texas Southwestern, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Nagre-recruitPhase 1

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT05892718

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Nagre-recruitObservasyonal na pag-aaral

Ut Southwestern, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT06357754

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Nagre-recruitObservasyonal na pag-aaral

University of Texas Southwestern, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Okt 22, 2025 · NCT02848274

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

Nagre-recruitPhase 1/2

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2022 · NCT04502394

Pag-aaral para sa Non-Hodgkin Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.